Cost-effectiveness evidence on approved cancer drugs in Ireland: the limits of data availability and implications for public accountability

BACKGROUND: We surveyed evidence published by Ireland’s National Centre for Pharmacoeconomics (NCPE) on the cost-effectiveness of cancer drugs approved for funding within the Irish public healthcare system. The purpose is threefold: to assess the completeness and clarity of publicly available cost-e...

Descripción completa

Detalles Bibliográficos
Autores principales: Almajed, Suaad, Alotaibi, Nora, Zulfiqar, Sana, Dhuhaibawi, Zahraa, O’Rourke, Niall, Gaule, Richard, Byrne, Caoimhe, Barry, Aaron M., Keeley, Dylan, O’Mahony, James F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964600/
https://www.ncbi.nlm.nih.gov/pubmed/34460007
http://dx.doi.org/10.1007/s10198-021-01365-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964600/
https://www.ncbi.nlm.nih.gov/pubmed/34460007
http://dx.doi.org/10.1007/s10198-021-01365-2

Ejemplares similares